Cargando…

Migraine during COVID-19: Data from Second Wave Pandemic in an Italian Cohort

Objectives: The study aims to assess the impact of the second COVID-19 pandemic wave on migraine characteristics. Methods: This is an observational cross-sectional study conducted on migraine patients previously interviewed during the first Italian pandemic outbreak. A second structured telephone in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gentile, Eleonora, Delussi, Marianna, Abagnale, Chiara, Caponnetto, Valeria, De Cesaris, Francesco, Frattale, Ilaria, Guaschino, Elena, Marcinnò, Andrea, Ornello, Raffaele, Pistoia, Francesca, Putortì, Alessia, Candida, Giusy, Roveta, Fausto, Lupi, Chiara, Coppola, Gianluca, Prudenzano, Addolorata Maria Pia, Rainero, Innocenzo, Sances, Grazia, Roca, Maria Elena, Trojano, Maria, Pierelli, Francesco, Geppetti, Pierangelo, Sacco, Simona, de Tommaso, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070557/ https://www.ncbi.nlm.nih.gov/pubmed/33920175 http://dx.doi.org/10.3390/brainsci11040482

Ejemplares similares

Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe)
por: Delussi, Marianna, et al.
Publicado: (2020)

Effects of COVID-19 on a migrainous patient treated with erenumab: A case report
por: Grassini, Alberto, et al.
Publicado: (2021)

P010. OnabotulinumtoxinA for treatment of chronic migraine: results after 1 year of treatment
por: Rossi, Eleonora, et al.
Publicado: (2015)

Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraine
por: Sacco, Simona, et al.
Publicado: (2019)

TRPA1 and other TRP channels in migraine
por: Benemei, Silvia, et al.
Publicado: (2013)

Decreased resistin plasmatic concentrations in patients with Alzheimer's disease: A case-control study
por: Marcinnò, Andrea, et al.
Publicado: (2022)

Investigating p62 Concentrations in Cerebrospinal Fluid of Patients with Dementia: A Potential Autophagy Biomarker In Vivo?
por: Rubino, Elisa, et al.
Publicado: (2022)

Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ)
por: Onofri, Agnese, et al.
Publicado: (2023)

Impact of COVID-19 on chronic migraine treated with erenumab: a case report
por: Grassini, Alberto, et al.
Publicado: (2021)

Aβ42 as a Biomarker of Alzheimer’s Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?
por: Boschi, Silvia, et al.
Publicado: (2022)

Emerging Pharmacological Treatments for Migraine in the Pediatric Population
por: Iannone, Luigi Francesco, et al.
Publicado: (2022)

CGRP receptors and TRP channels in migraine
por: Geppetti, Pierangelo, et al.
Publicado: (2015)

Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series
por: Ornello, Raffaele, et al.
Publicado: (2021)

P057. Prophylaxis with low-dose methadone in patients affected by daily refractory headache and medication-overuse headache: a prospective cohort study (METACEF study)
por: Lupi, Chiara, et al.
Publicado: (2015)

Polymorphisms of the Proinflammatory Cytokine Genes Modulate the Response to NSAIDs but Not to Triptans in Migraine Attacks
por: Rubino, Elisa, et al.
Publicado: (2022)

COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report
por: Iannone, Luigi Francesco, et al.
Publicado: (2021)

Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study
por: Benemei, Silvia, et al.
Publicado: (2020)

Analysis of the DNA methylation pattern of the promoter region of calcitonin gene-related peptide 1 gene in patients with episodic migraine: An exploratory case-control study
por: Rubino, Elisa, et al.
Publicado: (2022)

Increased orexin A concentrations in cerebrospinal fluid of patients with behavioural variant frontotemporal dementia
por: Roveta, Fausto, et al.
Publicado: (2021)

Protocol and methods for testing the efficacy of well-being therapy in chronic migraine patients: a randomized controlled trial
por: Mansueto, Giovanni, et al.
Publicado: (2018)

Different effects of air microembolism through patent foramen ovale in patients with migraine: A quantitative electroencephalogram case series
por: Ornello, Raffaele, et al.
Publicado: (2022)

Patterns of Migraine in Postmenopausal Women: A Systematic Review
por: Ornello, Raffaele, et al.
Publicado: (2021)

Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
por: Iannone, Luigi Francesco, et al.
Publicado: (2022)

Acute and Preventive Management of Migraine during Menstruation and Menopause
por: Ornello, Raffaele, et al.
Publicado: (2021)

Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study
por: De Matteis, Eleonora, et al.
Publicado: (2022)

A Novel PSEN1 Variant Leading to Posterior Cortical Atrophy: A Case Report
por: Roveta, Fausto, et al.
Publicado: (2023)

Effectiveness of Transcranial Direct Current Stimulation and Monoclonal Antibodies Acting on the CGRP as a Combined Treatment for Migraine (TACTIC): Protocol for a Randomized, Double-Blind, Sham-Controlled Trial
por: Ornello, Raffaele, et al.
Publicado: (2022)

Migraine-provoking substances evoke periorbital allodynia in mice
por: De Logu, Francesco, et al.
Publicado: (2019)

Medicines for headache before and during pregnancy: a retrospective cohort study (ATENA study)
por: Lupi, Chiara, et al.
Publicado: (2020)

The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal
por: Ornello, Raffaele, et al.
Publicado: (2019)

Correction to: Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial
por: Grazzi, Licia, et al.
Publicado: (2019)

Correction to: Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial
por: Martelletti, Paolo, et al.
Publicado: (2018)

Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial
por: Martelletti, Paolo, et al.
Publicado: (2018)

Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial
por: Grazzi, Licia, et al.
Publicado: (2018)

Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism
por: Di Lorenzo, Cherubino, et al.
Publicado: (2009)

The Carers’ Needs Assessment for Dementia (CNA-D): a validation study in the Italian population
por: Zucca, Milena, et al.
Publicado: (2021)

Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region
por: Ornello, Raffaele, et al.
Publicado: (2020)

Association between response to triptans and response to erenumab: real-life data
por: Frattale, Ilaria, et al.
Publicado: (2021)

Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study
por: Tassorelli, Cristina, et al.
Publicado: (2018)

Which is the best transcranial direct current stimulation protocol for migraine prevention? A systematic review and critical appraisal of randomized controlled trials
por: Ornello, Raffaele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5murb4hbgjec3agj80j2n9j64e